History

Dr Andrew Reynolds studied for his BSc in Molecular Cell Biology at the University of Southampton. He then moved to the Imperial Cancer Research Fund laboratories in London (now the Cancer Research UK London Research Institute) to undertake his PhD in the area of growth factor receptor signalling. He then worked as a Postdoctoral Fellow at St. Thomas Hospital and St. Barts Hospital where he specialised in angiogenesis research. In 2007, he was appointed leader of the Tumour Angiogenesis Group at the Breakthrough Breast Cancer Research Centre and in 2010 was appointed Team Leader of Tumour Angiogenesis.